Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (year values) |
||||||||
2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | |||
EV/EBITDA | ? | -5.35 | -3.46 | -3.48 | -2.06 | -0.69 | -1.07 | |
Changes by years, y/y, % | -322% | -35% | +0% | -41% | -66% |
Arcutis Biotherapeutics. EV/EBITDA
Arcutis Biotherapeutics. EV/EBITDA, changes, %
Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EV/EBITDA | ? | -1.02 | -4.75 | -5.52 | -6.07 | -6.12 | -1.07 | |
Changes by years, y/y, % | -57% | +167% | +210% | +254% | +372% | |||
Changes by quarters, q/q, % | -22% | +368% | +16% | +10% | +1% |